129 related articles for article (PubMed ID: 31736183)
1. Incidence and predictors of treatment-related conjugated hyperbilirubinemia during early treatment phases for children with acute lymphoblastic leukemia.
Hashmi SK; Navai SA; Chambers TM; Scheurer ME; Hicks MJ; Rau RE; Gramatges MM
Pediatr Blood Cancer; 2020 Feb; 67(2):e28063. PubMed ID: 31736183
[TBL] [Abstract][Full Text] [Related]
2. Predictors of hepatotoxicity and pancreatitis in children and adolescents with acute lymphoblastic leukemia treated according to contemporary regimens.
Denton CC; Rawlins YA; Oberley MJ; Bhojwani D; Orgel E
Pediatr Blood Cancer; 2018 Mar; 65(3):. PubMed ID: 29218844
[TBL] [Abstract][Full Text] [Related]
3. Outcome and toxicities associated to chemotherapy in children with acute lymphoblastic leukemia and Gilbert syndrome. Usefulness of UGT1A1 mutational screening.
Berrueco R; Alonso-Saladrigues A; Martorell-Sampol L; Català-Temprano A; Ruiz-Llobet A; Toll T; Torrebadell M; Naudó M; Camós M; Rives S
Pediatr Blood Cancer; 2015 Jul; 62(7):1195-201. PubMed ID: 25855413
[TBL] [Abstract][Full Text] [Related]
4. Obesity in pediatric patients with acute lymphoblastic leukemia increases the risk of adverse events during pre-maintenance chemotherapy.
Meenan CK; Kelly JA; Wang L; Ritchey AK; Maurer SH
Pediatr Blood Cancer; 2019 Feb; 66(2):e27515. PubMed ID: 30362242
[TBL] [Abstract][Full Text] [Related]
5. Chemotherapy-related hyperbilirubinemia in pediatric acute lymphoblastic leukemia: a genome-wide association study from the AIEOP-BFM ALL study group.
Junk SV; Schaeffeler E; Zimmermann M; Möricke A; Beier R; Schütte P; Fedders B; Alten J; Hinze L; Klein N; Kulozik A; Muckenthaler MU; Koehler R; Borkhardt A; Vijayakrishnan J; Ellinghaus D; Forster M; Franke A; Wintering A; Kratz CP; Schrappe M; Schwab M; Houlston RS; Cario G; Stanulla M
J Exp Clin Cancer Res; 2023 Jan; 42(1):21. PubMed ID: 36639636
[TBL] [Abstract][Full Text] [Related]
6. Association of Inherited Genetic Factors With Drug-Induced Hepatic Damage Among Children With Acute Lymphoblastic Leukemia.
Yang W; Karol SE; Hoshitsuki K; Lee S; Larsen EC; Winick N; Carroll WL; Loh ML; Raetz EA; Hunger SP; Winter SS; Dunsmore KP; Devidas M; Relling MV; Yang JJ
JAMA Netw Open; 2022 Dec; 5(12):e2248803. PubMed ID: 36580335
[TBL] [Abstract][Full Text] [Related]
7. Abnormal liver transaminases and conjugated hyperbilirubinemia at presentation of acute lymphoblastic leukemia.
Segal I; Rassekh SR; Bond MC; Senger C; Schreiber RA
Pediatr Blood Cancer; 2010 Sep; 55(3):434-9. PubMed ID: 20658613
[TBL] [Abstract][Full Text] [Related]
8. Chemotherapy-induced unconjugated hyperbilirubinemia caused by a mutation of the bilirubin uridine-5'-diphosphate-glucuronosyltransferase gene.
Maruo Y; Sato H; Bamba N; Iwai M; Sawa H; Fujino H; Taga T; Ota S; Shimada M
J Pediatr Hematol Oncol; 2001 Jan; 23(1):45-7. PubMed ID: 11196269
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness of antibacterial prophylaxis during induction chemotherapy in children with acute lymphoblastic leukemia.
Sulis ML; Blonquist TM; Stevenson KE; Hunt SK; Kay-Green S; Athale UH; Clavell LA; Cole PD; Kelly KM; Laverdiere C; Leclerc JM; Michon B; Schorin MA; Welch JG; Neuberg DS; Sallan SE; Silverman LB
Pediatr Blood Cancer; 2018 May; 65(5):e26952. PubMed ID: 29319209
[TBL] [Abstract][Full Text] [Related]
10. Prevalence and management of constipation in pediatric acute lymphoblastic leukemia in U.S. children's hospitals.
Belsky JA; Stanek JR; O'Brien SH
Pediatr Blood Cancer; 2020 Nov; 67(11):e28659. PubMed ID: 32893981
[TBL] [Abstract][Full Text] [Related]
11. High-dose methotrexate administration and acute liver damage in children treated for acute lymphoblastic leukemia. A prospective study.
Locasciulli A; Mura R; Fraschini D; Gornati G; Scovena E; Gervasoni A; Uderzo C; Masera G
Haematologica; 1992; 77(1):49-53. PubMed ID: 1398282
[TBL] [Abstract][Full Text] [Related]
12. Improved Outcome of a Pediatric-Inspired Protocol for High-Risk Adolescent and Young Adult Acute Lymphoblastic Leukemia Patients Using Peg-Asparaginase and Escalating Dose of Methotrexate: Tolerability and Outcome.
Hanbali A; Kotb A; El Fakih R; Alfraih F; Ahmed SO; Shaheen M; Hashmi S; Alhayli S; Alahmari A; Riash MA; Rasheed W; Alzahrani H; Alsharif F; Chaudhri N; Almohareb F; Aljurf M
Clin Lymphoma Myeloma Leuk; 2019 Oct; 19(10):670-677. PubMed ID: 31377206
[TBL] [Abstract][Full Text] [Related]
13. Comparing osteonecrosis clinical phenotype, timing, and risk factors in children and young adults treated for acute lymphoblastic leukemia.
Mogensen SS; Harila-Saari A; Mäkitie O; Myrberg IH; Niinimäki R; Vestli A; Hafsteinsdottir S; Griškevicius L; Saks K; Hallböök H; Retpen J; Helt LR; Toft N; Schmiegelow K; Frandsen TL;
Pediatr Blood Cancer; 2018 Oct; 65(10):e27300. PubMed ID: 29943905
[TBL] [Abstract][Full Text] [Related]
14. Impact of DARC, GSDMA and CXCL2 polymorphisms on induction toxicity in children with acute lymphoblastic leukemia: A complementary study.
Gatineau-Sailliant S; Glisovic S; Gagné V; Laverdière C; Leclerc JM; Silverman LB; Sinnett D; Krajinovic M; Pastore Y
Leuk Res; 2019 Nov; 86():106228. PubMed ID: 31590117
[No Abstract] [Full Text] [Related]
15. Obesity and outcome in pediatric acute lymphoblastic leukemia.
Butturini AM; Dorey FJ; Lange BJ; Henry DW; Gaynon PS; Fu C; Franklin J; Siegel SE; Seibel NL; Rogers PC; Sather H; Trigg M; Bleyer WA; Carroll WL
J Clin Oncol; 2007 May; 25(15):2063-9. PubMed ID: 17513811
[TBL] [Abstract][Full Text] [Related]
16. Incidence and Risk Factors for Hypertension During Childhood Acute Lymphoblastic Leukemia Therapy.
Malhotra P; Kapoor G; Jain S; Garg B
Indian Pediatr; 2018 Oct; 55(10):877-879. PubMed ID: 29941701
[TBL] [Abstract][Full Text] [Related]
17. Hepatic sinusoidal obstruction syndrome during maintenance therapy of childhood acute lymphoblastic leukemia is associated with continuous asparaginase therapy and mercaptopurine metabolites.
Toksvang LN; De Pietri S; Nielsen SN; Nersting J; Albertsen BK; Wehner PS; Rosthøj S; Lähteenmäki PM; Nilsson D; Nystad TA; Grell K; Frandsen TL; Schmiegelow K
Pediatr Blood Cancer; 2017 Sep; 64(9):. PubMed ID: 28423235
[TBL] [Abstract][Full Text] [Related]
18. Infection-related complications during treatment for childhood acute lymphoblastic leukemia.
Inaba H; Pei D; Wolf J; Howard SC; Hayden RT; Go M; Varechtchouk O; Hahn T; Buaboonnam J; Metzger ML; Rubnitz JE; Ribeiro RC; Sandlund JT; Jeha S; Cheng C; Evans WE; Relling MV; Pui CH
Ann Oncol; 2017 Feb; 28(2):386-392. PubMed ID: 28426102
[TBL] [Abstract][Full Text] [Related]
19. Comparison of two schedules of intermediate-dose methotrexate and cytarabine consolidation therapy for childhood B-precursor cell acute lymphoblastic leukemia: a Pediatric Oncology Group study.
Land VJ; Shuster JJ; Crist WM; Ravindranath Y; Harris MB; Krance RA; Pinkel D; Pullen DJ
J Clin Oncol; 1994 Sep; 12(9):1939-45. PubMed ID: 8083715
[TBL] [Abstract][Full Text] [Related]
20. Asparaginase Toxicities: Identification and Management in Patients With Acute Lymphoblastic Leukemia
.
Thu Huynh V; Bergeron S
Clin J Oncol Nurs; 2017 Oct; 21(5):E248-E259. PubMed ID: 28945721
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
